Identification and characterization of PKCγ, a kinase associated with SCA14, as an amyloidogenic protein

Hideyuki Takahashi1, Naoko Adachi1, Toshihiko Shirafuji1

  • 1Biosignal Research Center, Kobe University, Kobe 657-8501, Japan.

Human Molecular Genetics
|September 14, 2014
PubMed

Insights

Protein kinase C gamma (PKCγ) forms amyloid-like fibrils, a process accelerated by mutations linked to spinocerebellar ataxia type 14 (SCA14). These mutant PKCγ aggregates are toxic to neuronal cells, revealing a new mechanism in neurodegenerative diseases.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Biochemistry

Background:

  • Amyloid assemblies are implicated in various human disorders, including Alzheimer's and Parkinson's diseases.
  • Protein kinase C (PKC) gamma is a serine/threonine kinase associated with spinocerebellar ataxia type 14 (SCA14).

Purpose of the Study:

  • To identify novel amyloidogenic proteins and understand their aggregation mechanisms.
  • To investigate the role of PKCγ in amyloid formation and its link to SCA14.

Main Methods:

  • Overexpression of PKCγ in cultured cells and in vitro incubation.
  • Time-lapse imaging to observe fibril formation and cellular toxicity.
  • Analysis of PKCγ domains (C1A and kinase) in aggregation.

Main Results:

  • PKCγ spontaneously forms amyloid-like fibrils in cells and in vitro.
  • SCA14-associated mutations accelerate PKCγ fibril formation and cause misfolding.
  • Mutant PKCγ aggregates exhibit significant toxicity to neuronal cells.

Conclusions:

  • PKCγ is a novel amyloidogenic protein, with potential implications in SCA14 pathogenesis.
  • Misfolding and aggregation of PKCγ, particularly in SCA14, contribute to neurodegeneration.
  • This study offers new insights into amyloid-like fibril formation in multi-domain proteins.